(Substituted)-benzo[b]thiophene-4-carboxamide Synthesis and Antiproliferative Activity Study

Author(s): Chandrakant Dhondiram Pawar, Dattatraya Navnath Pansare, Devanand Baburao Shinde*.

Journal Name: Letters in Drug Design & Discovery

Volume 17 , Issue 5 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Background: Thiophene ring forms important building block in medicinal chemistry. Literature reveals that thiophene ring in combination with different groups shows different activity. By keeping these things in mind we have designed and synthesized a new series of amide and sulfonamide coupled thiophene. A series of novel substituted 3-sulfamoylbenzo[b]thiophene-4- carboxamide molecules containing sulfonamide and amide group were designed, synthesized and used for anti-proliferative activity study.

Methods: The final compounds 16-36 were synthesized by using series of reactions comprising sulfonation, sulfonamide coupling, hydrolysis and peptide coupling. The yields of compounds 16- 36 are in the range of 90-98%. The structures of the synthesized compounds were elucidated and confirmed by 1H NMR, 13C NMR, LCMS and the purity was checked through HPLC analysis. The compounds were further tested for their in vitro anticancer activity against a series of cell lines A549, HeLa, MCF-7 and Du-145.

Results: The intermediates 8-13, 15 and final compounds 16-36 were synthesized in good yields. The synthesized compounds were further tested for their anticancer activity and most of compounds showed moderate to good anticancer activity against all four cell lines.

Conclusion: We have synthesized 21 compounds and were screened for anticancer activity against MCF-7, HeLa, A-549 and Du-145 cancer cell lines. Most of the compounds were active for tested cell lines with IC50 value in the range of 1.81 to 9.73 μM. The compounds 18, 19, 21, 25, 30, 31 and 33 are most active in cell line data with IC50 value in the range of 1.81 to 2.52 μM.

Keywords: Sulfonamide, benzo[b]-thiophene-4-carboxamide, anticancer activity, anti proliferative activity, 1H NMR, 13C NMR.

Pingaew, R.; Prachayasittikul, V.; Worachartcheewan, A.; Nantasenamat, C.; Prachayasittikul, S.; Ruchirawat, S.; Prachayasittikul, V. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies. Eur. J. Med. Chem., 2015, 103, 446-459.
[http://dx.doi.org/10.1016/j.ejmech.2015.09.001] [PMID: 26397393]
Kumar, M.; Narasimhan, B.; Kumar, P.; Ramasamy, K.; Mani, V.; Mishra, R.K.; Majeed, A.B. 4-(1-Aryl-5-chloro-2-oxo-1,2-dihydro-indol-3-ylideneamino)-N-substituted benzene sulfonamides: Synthesis, antimicrobial, anticancer evaluation and QSAR studies. Arab. J. Chem., 2014, 7, 436-447.
Pawar, C.D.; Shinde, D.B. Synthesis and antimicrobial evaluation of novel sulfonyl and amide coupling derivatives. EC Microbiology., 2017, 8, 14-28.
Nasr, T.; Bondock, S.; Eid, S. Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety. Eur. J. Med. Chem., 2014, 84, 491-504.
[http://dx.doi.org/10.1016/j.ejmech.2014.07.052] [PMID: 25050881]
Mobkhot, Y.N.; Kheder, N.A.; Barakat, A.; Choudhary, M.I.; Yousuf, S.; Frey, W. Synthesis, antimicrobial, anti-cancer and molecular docking of two novel hitherto unreported thiophenes. Rsc. Adv., 2016, 6, 63724-63729.
Sharif, M.; Shoaib, K.; Ahmed, S.; Iqbal, J.; Abilov, Z.A.; Spannenbery, A.; Langer, P. Suzuki-Miyaura reactions of 3,5-dichloro-2,4,6-trifluoropyridine. Tetra. Lett., 2016, 57, 3060-3062.
Abe, T.; Mino, T.; Watanabe, K.; Sakamoto, M. Suzuki-Miyaura coupling of aryl chlorides with arylboronic acids using the morpholine-NiCl2 catalyst system. Eur. J. Org. Chem., 2014, 31, 6983-6991.
Berrade, L.; Aisa, B.; Ramirez, M.J.; Galiano, S.; Guccione, S.; Moltzau, L.R.; Levy, F.O.; Nicoletti, F.; Battaglia, G.; Molinaro, G.; Aldana, I.; Monge, A.; Perez-Silanes, S. Novel benzo[b]thiophene derivatives as new potential antidepressants with rapid onset of action. J. Med. Chem., 2011, 54(8), 3086-3090.
[http://dx.doi.org/10.1021/jm2000773] [PMID: 21469694]
Lim, C.J.; Woo, S.E.; Ko, S.I.; Lee, B.H.; Oh, K.S.; Yi, K.Y. Benzo[b]thiophene-2-carboxamide derivatives as potent urotensin-II receptor antagonists. Bioorg. Med. Chem. Lett., 2016, 26(19), 4684-4686.
[http://dx.doi.org/10.1016/j.bmcl.2016.08.049] [PMID: 27597245]
Hansen, F.K.; Khankischpur, M.; Tolaymat, I.; Mesaros, R.; Dannhardt, G.; Geffken, D. Efficient synthesis and 5-LOX/COX-inhibitory activity of some 3-hydroxybenzo[b]thiophene-2-carboxylic acid derivatives. Bioorg. Med. Chem. Lett., 2012, 22(15), 5031-5034.
[http://dx.doi.org/10.1016/j.bmcl.2012.06.012] [PMID: 22749420]
Masaki, H.; Mizuno, Y.; Tatui, A.; Murakami, A.; Koide, Y.; Satoh, S.; Takahashi, A. Structure-activity relationship of benzo[b]thiophene-2-sulfonamide derivatives as novel human chymase inhibitors. Bioorg. Med. Chem. Lett., 2003, 13(22), 4085-4088.
[http://dx.doi.org/10.1016/j.bmcl.2003.08.040] [PMID: 14592513]
Amr, Ael-G.; Sherif, M.H.; Assy, M.G.; Al-Omar, M.A.; Ragab, I. Antiarrhythmic, serotonin antagonist and antianxiety activities of novel substituted thiophene derivatives synthesized from 2-amino-4,5,6,7-tetrahydro-N-phenylbenzo[b]thiophene-3-carboxamide. Eur. J. Med. Chem., 2010, 45(12), 5935-5942.
[http://dx.doi.org/10.1016/j.ejmech.2010.09.059] [PMID: 20950897]
Pinney, K.G.; Bounds, A.D.; Dingeman, K.M.; Mocharla, V.P.; Pettit, G.R.; Bai, R.; Hamel, E. A new anti-tubulin agent containing the benzo[b]thiophene ring system. Bioorg. Med. Chem. Lett., 1999, 9(8), 1081-1086.
[http://dx.doi.org/10.1016/S0960-894X(99)00143-2] [PMID: 10328289]
Galiano, S.; Erviti, O.; Pérez, S.; Moreno, A.; Juanenea, L.; Aldana, I.; Monge, A. Synthesis of new thiophene and benzo[b]thiophene hydrazide derivatives as human NPY Y(5) antagonists. Bioorg. Med. Chem. Lett., 2004, 14(3), 597-599.
[http://dx.doi.org/10.1016/j.bmcl.2003.11.070] [PMID: 14741250]
Keri, R.S.; Chand, K.; Budagumpi, S.; Balappa Somappa, S.; Patil, S.A.; Nagaraja, B.M. An overview of benzo[b]thiophene-based medicinal chemistry. Eur. J. Med. Chem., 2017, 138, 1002-1033.
[http://dx.doi.org/10.1016/j.ejmech.2017.07.038] [PMID: 28759875]
Kilsheimer, J.R.; Kaufman, H.A.; Foster, H.M.; Driscoll, P.R.; Glick, L.A.; Napier, R.P. Benzo[b]thienyl carbamate insecticides. J. Agric. Food Chem., 1969, 17, 91-93.
Pawar, C.D.; Sarkate, A.P.; Karnik, K.S.; Pansare, D.N.; Shinde, D.B. Synthesis and evaluation of N-(Substituted phenyl)-2-(3-substituted) sulfamoyl) phenyl) acetamide derivatives as anticancer Agents. Egyp. J. Basic Appl. Sci., 2017, 4, 310-314.
Pawar, C.D.; Sarkate, A.P.; Karnik, K.S.; Bahekar, S.S.; Pansare, D.N.; Shelke, R.N.; Jawale, C.S.; Shinde, D.B. Synthesis and antimicrobial evaluation of novel ethyl 2-(2-(4-substituted)acetamido)-4-subtituted-thiazole-5-carboxylate derivatives. Bioorg. Med. Chem. Lett., 2016, 26(15), 3525-3528.
[http://dx.doi.org/10.1016/j.bmcl.2016.06.030] [PMID: 27324976]
Pawar, C.D.; Pansare, D.N.; Shinde, D.B. Synthesis and antiproliferative activity of 3-(substituted)-4,5,6,7-tetrahydro-6-(substituted)-1H-pyrazolo[3,4-c]pyridine derivatives. Eur. J. Chem., 2017, 8, 400-409.
Pawar, C.D.; Sarkate, A.P.; Karnik, K.S.; Pansare, D.N.; Shinde, D.B. Synthesis and antiproliferative evaluation of new (4-substituted-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)methane substituted sulfonamide derivatives. Eur. J. Chem., 2017, 8, 384-390.
Arnold, L. D.; Maag, H.; Turner, J. W. W. Hepatitis b viral assembly effectors PCT Int., Appl., 2016., US10220034B2.
Conner, S. E.; Gossett, L. S.; Green, J. E.; Jones, W. D., Jr; Eli, L. C.; Mantlo, N. B.; Matthews, D. P.; Mayhugh, D. R.; Smith, D. L.; Vance, J. A.; Wang, X.; Warshawsky, A. M.; Winneroski, L. L., Jr; Xu, Y.; Zhu, G. Sulfonamide derivatives as ppar modulators PCT Int., Appl., 2004, US7655641B2.
Park, C.M.; Kim, S.Y.; Park, W.K.; Park, N.S.; Seong, C.M. Synthesis and structure-activity relationship of 1H-indole-3-carboxylic acid pyridine-3-ylamides: A novel series of 5-HT2C receptor antagonists. Bioorg. Med. Chem. Lett., 2008, 18(14), 3844-3847.
[http://dx.doi.org/10.1016/j.bmcl.2008.06.064] [PMID: 18602261]
Bebernitz, G.R.; Beaulieu, V.; Dale, B.A.; Deacon, R.; Duttaroy, A.; Gao, J.; Grondine, M.S.; Gupta, R.C.; Kakmak, M.; Kavana, M.; Kirman, L.C.; Liang, J.; Maniara, W.M.; Munshi, S.; Nadkarni, S.S.; Schuster, H.F.; Stams, T.; St Denny, I.; Taslimi, P.M.; Vash, B.; Caplan, S.L. Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes. J. Med. Chem., 2009, 52(19), 6142-6152.
[http://dx.doi.org/10.1021/jm900839k] [PMID: 19746978]
Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 1990, 82(13), 1107-1112.
[http://dx.doi.org/10.1093/jnci/82.13.1107] [PMID: 2359136]

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [563 - 573]
Pages: 11
DOI: 10.2174/1570180815666181004114125
Price: $65

Article Metrics

PDF: 16